Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Primary, Accumulated Irritability and Sensitization Potential of EF192A Under Controlled and Maximized Conditions

NCT06731062 is registered in ClinicalTrials.gov with Eurofarma Laboratorios S.A. as lead sponsor.

NCT NCT06731062
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06731062 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Primary, Accumulated Irritability and Sensitization Potential of EF192A Under Controlled and Maximized Conditions
Lead sponsor
Eurofarma Laboratorios S.A.
Phase
Not applicable
Overall status
Completed
Start date
January 20, 2025
Completion date
February 28, 2025
Enrollment
88 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

skin care, skin lesion, skin lesions